Pharmaron Beijing Co., Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40004291

Informations générales

Localisation

China

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

11/07/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2033

Statut

Targets set

Classification

1.5°C

Année cible

2033

Progression vers l'objectif61%
2015 (année de référence)2033
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target: Pharmaron Beijing Co., Ltd. commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Pharmaron Beijing Co., Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 54.60% by 2033 from 2023 base year. Pharmaron Beijing Co., Ltd. also commits to reduce scope 3 GHG emissions 61.07% per million CNY value added within the same timeframe. Long-Term Targets: Pharmaron Beijing Co., Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2021 base year. Pharmaron Beijing Co., Ltd. also commits to reduce scope 3 GHG emissions 97% per million CNY value added within the same timeframe.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

30/06/2022

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

CNE100003JW4

LEI

300300JYXHGVS5SNGG54

Source : Science Based Targets initiative | Données publiques